Over the weekend, a swine flu virus, influenza A (H1N1) strain, has appeared in
At this time, GSK is collaborating fully with WHO and governments in their efforts to understand the outbreaks and respond appropriately with respond appropriately with existing antivirals, and potential vaccine and consumer healthcare products. We are also working with health authorities to explore if the seasonal flu vaccines may offer protection against swine flu.
At this point, we, as a company, are not activating our full pandemic preparedness plans in
What you can do:
Stay calm and informed. The Centers for Disease Control and Prevention (CDC) have posted general information on swine flu. If you develop signs and symptoms of flu (rapid onset of fever, joint and muscle aches, headache, etc), stay home and contact your doctor within 24 hours to determine if treatment is needed.
GSK continues to closely monitor the situation with the WHO and other national agencies, and stands ready to initiate discussions with local authorities for the manufacture of a vaccine to help prevent this new influenza strain, once a suitable candidate vaccine strain is available from the WHO.